Tuesday June 18, 2019

Pancreatic Cancer: Cannabis Compound May Boost Survival

While the current study only looked at the effect of CBD in mice, clinical trials in humans are needed to confirm whether or not CBD improves survival rates of pancreatic cancer patients

0
//
Cannabis
Cannabis extract may offer treatment for psychosis: Study. Pixabay

A naturally occurring constituent of medicinal cannabis along with chemotherapy could increase the survival rate by three times among mice with pancreatic cancer, according to a new study.

According to the researchers, the cannabinoid named Cannabidiol (CBD) does not cause psychoactive effects and has been already cleared for use at the clinics.

“This is a remarkable result. We found that mice with pancreatic cancer survived nearly three times longer if a constituent of medicinal cannabis was added to their chemotherapy treatment,” said lead author Marco Falasca from Queen Mary University of London in Britain.

“Cannabidiol is already approved for use in clinics, which means we can quickly go on to test this in human clinical trials. If we can reproduce these effects in humans, cannabidiol could be in use in cancer clinics almost immediately, compared to having to wait for authorities to approve a new drug,” he added.

Cannabis
Cannabis leaf. Pixabay

For the study, published in the journal Oncogene, the team tested the impact of the cannabidiol on the use of the commonly used chemotherapy medication Gemcitabine as a treatment for pancreatic cancer in mice.

“Given the five-year survival rate for people with pancreatic cancer is less than seven per cent, the discovery of new treatments and therapeutic strategies is urgently needed,” Falasca noted.

Also Read: Research: Gene Linked to Hair Loss May Improve Cancer Treatment

The team explained that CBD is also known to improve the side effects of chemotherapy, including nausea, diarrhoea, vomiting, meaning it could also improve the quality of life of patients undergoing chemotherapy.

While the current study only looked at the effect of CBD in mice, clinical trials in humans are needed to confirm whether or not CBD improves survival rates of pancreatic cancer patients, the researchers said. (IANS)

Next Story

GRAIL Announces Significant Progress on Blood Tests to Detect Cancer

Grail's new results are from 2,300 people

0
GRAIL, Blood Tests, Detect, Cancer
FILE A patient has her blood drawn at a hospital in Philadelphia to monitor her cancer treatment. VOA

A California company says its experimental blood test was able to detect many types of cancer at an early stage and gave very few false alarms in a study that included people with and without the disease.

Many companies are trying to develop early detection “liquid biopsy” tests that capture bits of DNA that cancer cells shed into blood.

GRAIL, Blood Tests, Detect, Cancer
A California company says its experimental blood test was able to detect many types of cancer at an early stage. VOA

Grail’s new results are from 2,300 people. The test detected 55% of known cancers and gave false alarms for 1%. It also accurately suggested where the cancer may be about 90% of the time.

Also Read- US Removes Eritrea From Counterterror Non-Cooperaltion List

The company gave results in news release Friday and will report them Saturday at a conference in Chicago. They have not been published or reviewed by other scientists. (VOA)